Overall, our work illuminates the potential mechanism of how the tumor suppressive E3 ubiquitin ligase SMURF2 could be inactivated in human cancer through the alterations in its subcellular localization, and connects the altered biodistribution of SMURF2 to human carcinogenesis. This evidence concerns the gene SMURF2 and cancer.